HomeQuestion

Are you treating with the superoxide dismutase mimetic Avasopasem (GC4419) for patients receiving chemoradiation for head & neck cancers?

1 Answers

Mednet Member

Radiation Oncology · University of Iowa

This drug is not yet FDA-approved. It is currently under review by the FDA. I plan to use it after it is approved.

Are you treating with the superoxide dismutase mimetic Avasopasem (GC4419) for patients receiving chemoradiation for head & neck cancers? | Mednet